Tactile Systems Technology (TCMD) Free Cash Flow Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 6.28% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 9.63% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 22.80% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 29.36% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -27.72% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -0.27% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 77.20% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -20.37% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.32% |
| 10 | Tactile Systems Technology | 539.21 Mn | 449.02 Mn | 57.61 Mn | -16.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.01% |
| Dec 31, 2025 | 63.99% |
| Sep 30, 2025 | 121.01% |
| Jun 30, 2025 | 89.75% |
| Mar 31, 2025 | 26.23% |
| Dec 31, 2024 | 49.78% |
| Sep 30, 2024 | 96.20% |
| Jun 30, 2024 | 119.63% |
| Mar 31, 2024 | 34.28% |
| Dec 31, 2023 | 55.93% |
| Sep 30, 2023 | -8.01% |
| Jun 30, 2023 | 50.75% |
| Mar 31, 2023 | -49.61% |
| Dec 31, 2022 | 76.74% |
| Sep 30, 2022 | 42.65% |
| Jun 30, 2022 | 51.12% |
| Mar 31, 2022 | -101.30% |
| Dec 31, 2021 | 10.40% |
| Sep 30, 2021 | -33.53% |
| Jun 30, 2021 | -43.87% |
| Mar 31, 2021 | 26.15% |
| Dec 31, 2020 | 24.84% |
| Sep 30, 2020 | 22.26% |
| Jun 30, 2020 | -37.77% |
| Mar 31, 2020 | 36.48% |
| Dec 31, 2019 | -34.68% |
| Sep 30, 2019 | -31.49% |
| Jun 30, 2019 | -45.71% |
| Mar 31, 2019 | 36.80% |
| Dec 31, 2018 | 13.63% |
| Sep 30, 2018 | 161.50% |